Submission Details
| 510(k) Number | K222511 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2022 |
| Decision Date | November 21, 2023 |
| Days to Decision | 459 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K222511 is an FDA 510(k) clearance for the Oxy2Pro, a Analyzer, Gas, Carbon-dioxide, Gaseous-phase (Class II — Special Controls, product code CCK), submitted by Southmedic, Inc. (Barrie, CA). The FDA issued a Cleared decision on November 21, 2023, 459 days after receiving the submission on August 19, 2022. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.1400.
| 510(k) Number | K222511 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2022 |
| Decision Date | November 21, 2023 |
| Days to Decision | 459 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CCK — Analyzer, Gas, Carbon-dioxide, Gaseous-phase |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.1400 |